Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 12/20 | 0.55 |
| ▸ | KDR | P35968 | 7/20 | 0.50 |
| ▸ | PDGFRA | P16234 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | AXL | P30530 | 2/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19689586 | 0.85 | MET (0.47) | METKDRPDGFRA | |
| SCHEMBL371811 | 0.85 | MET (0.64) | METKDRPOLBAXL | |
| SCHEMBL29693647 | 0.84 | MET (0.49) | METKDRPDGFRAAXL | |
| SCHEMBL372095 | 0.80 | MET (0.68) | METKDRPOLB | |
| SCHEMBL2329031 | 0.78 | KDR (0.52) | METKDRPDGFRAHDAC1 | |
| SCHEMBL15062477 | 0.77 | MET (0.58) | METKDRPDGFRAAXL | |
| SCHEMBL9987209 | 0.77 | MET (0.62) | METKDRPDGFRAAXL | |
| SCHEMBL5223147 | 0.76 | MET (0.58) | METKDRAXL | |
| SCHEMBL15266665 | 0.76 | MET (0.62) | METKDRPOLB | |
| SCHEMBL20216678 | 0.75 | MET (0.61) | METKDRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673085-A4 | C-MET MODULATORS AND METHODS OF USE | EXELIXIS INC (US) | 2008-12-10 | — | — | EP | disclosed |
| EP-1673085-A2 | C-MET MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005030140-A2 | C-MET MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2005-04-07 | — | — | WO | disclosed |